Estuary Capital Management LP Day One Biopharmaceuticals, Inc. Transaction History

Estuary Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$7.93 - $13.21 $3.09 Million - $5.15 Million	-389,928 Reduced 10.49%	3,326,849 $26.4 Billion
Q4 2024 Feb 14, 2025	BUY	$12.46 - $16.39 $12.1 Million - $15.9 Million	972,997 Added 35.46%	3,716,777 $47.1 Billion
Q3 2024 Nov 14, 2024	BUY	$12.72 - $16.03 $1.38 Million - $1.74 Million	108,510 Added 4.12%	2,743,780 $38.2 Billion
Q2 2024 Aug 14, 2024	BUY	$12.03 - $17.69 $12.3 Million - $18.1 Million	1,024,133 Added 63.57%	2,635,270 $36.3 Billion
Q1 2024 May 15, 2024	BUY	$13.56 - $17.46 $9.87 Million - $12.7 Million	728,240 Added 82.48%	1,611,137 $26.6 Billion
Q4 2023 Feb 14, 2024	BUY	$9.68 - $15.37 $8.55 Million - $13.6 Million	882,897 New	882,897 $12.9 Billion

188

69.3M

127K

85.5K

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $451M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

Get notified when there are updates to the investment portfolio of Estuary Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Estuary Capital Management LP with notifications on news.